A thought-provoking statement regarding the treatment of patients with peripheral arterial disease
Vasa
.
2023 Mar;52(2):77-80.
doi: 10.1024/0301-1526/a001055.
Authors
Mette Søgaard
1
2
,
Joakim Nordanstig
3
,
Nikolaj Eldrup
4
,
Christian-Alexander Behrendt
5
6
Affiliations
1
Department of Cardiology, Aalborg University Hospital, Denmark.
2
Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Faculty of Medicine, Aalborg University, Denmark.
3
Department of Molecular and Clinical Medicine, Institute of Medicine, The Sahlgrenska Academy, University of Gothenburg, Sweden.
4
Department of Vascular Surgery, Rigshospitalet, Copenhagen, Denmark.
5
Department of Vascular and Endovascular Surgery, Asklepios Clinic Wandsbek, Asklepios Medical School, Hamburg, Germany.
6
Brandenburg Medical School Theodor Fontane, Neuruppin, Germany.
PMID:
36872885
DOI:
10.1024/0301-1526/a001055
No abstract available
Publication types
Editorial
MeSH terms
Humans
Peripheral Arterial Disease*